Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Jan;76(1):70–75. doi: 10.1136/jnnp.2004.038158

Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator

L Derex 1, M Hermier 1, P Adeleine 1, J Pialat 1, M Wiart 1, Y Berthezene 1, F Philippeau 1, J Honnorat 1, J Froment 1, P Trouillas 1, N Nighoghossian 1
PMCID: PMC1739325  PMID: 15607998

Abstract

Objective: To evaluate clinical, biological, and pretreatment imaging variables for predictors of tissue plasminogen activator (tPA) related intracerebral haemorrhage (ICH) in stroke patients.

Methods: 48 consecutive patients with hemispheric stroke were given intravenous tPA within seven hours of symptom onset, after computed tomography (CT) and magnetic resonance imaging (MRI) of the brain. Baseline diffusion weighted (DWI) and perfusion weighted (PWI) imaging volumes, time to peak, mean transit time, regional cerebral blood flow index, and regional cerebral blood volume were evaluated. The distribution of apparent diffusion coefficient (ADC) values was determined within each DWI lesion.

Results: The symptomatic ICH rate was 8.3% (four of 48); the rate for any ICH was 43.8% (21 of 48). Univariate analysis showed that age, weight, history of hyperlipidaemia, baseline NIHSS score, glucose level, red blood cell count, and lacunar state on MRI were associated with ICH. However, mean 24 hour systolic blood pressure and a hyperdense artery sign on pretreatment CT were the only independent predictors of ICH. Patients with a hyperdense artery sign had larger pretreatment PWI and DWI lesion volumes and a higher NIHSS score. Analysis of the distribution of ADC values within DWI lesions showed that a greater percentage of pixels had lower ADCs (<400x10–6 mm2/s) in patients who experienced ICH than in those who did not.

Conclusion: Key clinical and biological variables, pretreatment CT signs, and MRI indices are associated with tPA related intracerebral haemorrhage.

Full Text

The Full Text of this article is available as a PDF (122.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams H. P., Jr, Bendixen B. H., Kappelle L. J., Biller J., Love B. B., Gordon D. L., Marsh E. E., 3rd Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35–41. doi: 10.1161/01.str.24.1.35. [DOI] [PubMed] [Google Scholar]
  2. Berger C., Fiorelli M., Steiner T., Schäbitz W. R., Bozzao L., Bluhmki E., Hacke W., von Kummer R. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001 Jun;32(6):1330–1335. doi: 10.1161/01.str.32.6.1330. [DOI] [PubMed] [Google Scholar]
  3. Bozzao L., Angeloni U., Bastianello S., Fantozzi L. M., Pierallini A., Fieschi C. Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. AJNR Am J Neuroradiol. 1991 Nov-Dec;12(6):1115–1121. [PMC free article] [PubMed] [Google Scholar]
  4. Brott T., Adams H. P., Jr, Olinger C. P., Marler J. R., Barsan W. G., Biller J., Spilker J., Holleran R., Eberle R., Hertzberg V. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul;20(7):864–870. doi: 10.1161/01.str.20.7.864. [DOI] [PubMed] [Google Scholar]
  5. Demchuk A. M., Morgenstern L. B., Krieger D. W., Linda Chi T., Hu W., Wein T. H., Hardy R. J., Grotta J. C., Buchan A. M. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999 Jan;30(1):34–39. doi: 10.1161/01.str.30.1.34. [DOI] [PubMed] [Google Scholar]
  6. Dijkhuizen Rick M., Asahi Minoru, Wu Ona, Rosen Bruce R., Lo Eng H. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model. Stroke. 2002 Aug;33(8):2100–2104. doi: 10.1161/01.str.0000023534.37670.f7. [DOI] [PubMed] [Google Scholar]
  7. Fazekas F., Kleinert R., Roob G., Kleinert G., Kapeller P., Schmidt R., Hartung H. P. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol. 1999 Apr;20(4):637–642. [PMC free article] [PubMed] [Google Scholar]
  8. Furlan A., Higashida R., Wechsler L., Gent M., Rowley H., Kase C., Pessin M., Ahuja A., Callahan F., Clark W. M. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999 Dec 1;282(21):2003–2011. doi: 10.1001/jama.282.21.2003. [DOI] [PubMed] [Google Scholar]
  9. Gisselsson L., Smith M. L., Siesjö B. K. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metab. 1999 Mar;19(3):288–297. doi: 10.1097/00004647-199903000-00007. [DOI] [PubMed] [Google Scholar]
  10. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Höxter G., Mahagne M. H. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA. 1995 Oct 4;274(13):1017–1025. [PubMed] [Google Scholar]
  11. Hamann G. F., del Zoppo G. J., von Kummer R. Hemorrhagic transformation of cerebral infarction--possible mechanisms. Thromb Haemost. 1999 Sep;82 (Suppl 1):92–94. [PubMed] [Google Scholar]
  12. Hart R. G., Easton J. D. Hemorrhagic infarcts. Stroke. 1986 Jul-Aug;17(4):586–589. doi: 10.1161/01.str.17.4.586. [DOI] [PubMed] [Google Scholar]
  13. Hermier Marc, Nighoghossian Norbert, Adeleine Patrice, Berthezène Yves, Derex Laurent, Yilmaz Hasan, Dugor Jean-François, Dardel Pascal, Cotton François, Philippeau Frédéric. Early magnetic resonance imaging prediction of arterial recanalization and late infarct volume in acute carotid artery stroke. J Cereb Blood Flow Metab. 2003 Feb;23(2):240–248. doi: 10.1097/01.WCB.0000043340.09081.7E. [DOI] [PubMed] [Google Scholar]
  14. Hornig C. R., Dorndorf W., Agnoli A. L. Hemorrhagic cerebral infarction--a prospective study. Stroke. 1986 Mar-Apr;17(2):179–185. doi: 10.1161/01.str.17.2.179. [DOI] [PubMed] [Google Scholar]
  15. Kidwell Chelsea S., Saver Jeffrey L., Villablanca J. Pablo, Duckwiler Gary, Fredieu Andre, Gough Kristi, Leary Megan C., Starkman Sidney, Gobin Y. Pierre, Jahan Reza. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002 Jan;33(1):95–98. doi: 10.1161/hs0102.101792. [DOI] [PubMed] [Google Scholar]
  16. Larrue V., von Kummer R R., Müller A., Bluhmki E. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001 Feb;32(2):438–441. doi: 10.1161/01.str.32.2.438. [DOI] [PubMed] [Google Scholar]
  17. Larrue V., von Kummer R., del Zoppo G., Bluhmki E. Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke. 1997 May;28(5):957–960. doi: 10.1161/01.str.28.5.957. [DOI] [PubMed] [Google Scholar]
  18. Lindsberg Perttu J., Soinne Lauri, Roine Risto O., Salonen Oili, Tatlisumak Turgut, Kallela Mikko, Häppölä Olli, Tiainen Marjaana, Haapaniemi Elena, Kuisma Markku. Community-based thrombolytic therapy of acute ischemic stroke in Helsinki. Stroke. 2003 May 8;34(6):1443–1449. doi: 10.1161/01.STR.0000071111.98505.C7. [DOI] [PubMed] [Google Scholar]
  19. Longstreth W. T., Jr, Bernick C., Manolio T. A., Bryan N., Jungreis C. A., Price T. R. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998 Sep;55(9):1217–1225. doi: 10.1001/archneur.55.9.1217. [DOI] [PubMed] [Google Scholar]
  20. Moulin T., Crépin-Leblond T., Chopard J. L., Bogousslavsky J. Hemorrhagic infarcts. Eur Neurol. 1994;34(2):64–77. doi: 10.1159/000117012. [DOI] [PubMed] [Google Scholar]
  21. Nighoghossian N., Hermier M., Adeleine P., Blanc-Lasserre K., Derex L., Honnorat J., Philippeau F., Dugor J. F., Froment J. C., Trouillas P. Old microbleeds are a potential risk factor for cerebral bleeding after ischemic stroke: a gradient-echo T2*-weighted brain MRI study. Stroke. 2002 Mar;33(3):735–742. doi: 10.1161/hs0302.104615. [DOI] [PubMed] [Google Scholar]
  22. Petitti N. The hyperdense middle cerebral artery sign. Radiology. 1998 Sep;208(3):687–688. doi: 10.1148/radiology.208.3.9722846. [DOI] [PubMed] [Google Scholar]
  23. Røhl L., Ostergaard L., Simonsen C. Z., Vestergaard-Poulsen P., Andersen G., Sakoh M., Le Bihan D., Gyldensted C. Viability thresholds of ischemic penumbra of hyperacute stroke defined by perfusion-weighted MRI and apparent diffusion coefficient. Stroke. 2001 May;32(5):1140–1146. doi: 10.1161/01.str.32.5.1140. [DOI] [PubMed] [Google Scholar]
  24. Schellinger Peter D., Fiebach Jochen B., Hacke Werner. Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke. 2003 Feb;34(2):575–583. [PubMed] [Google Scholar]
  25. Selim Magdy, Fink John N., Kumar Sandeep, Caplan Louis R., Horkan Clare, Chen Yi, Linfante Italo, Schlaug Gottfried. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke. 2002 Aug;33(8):2047–2052. doi: 10.1161/01.str.0000023577.65990.4e. [DOI] [PubMed] [Google Scholar]
  26. Tanne David, Kasner Scott E., Demchuk Andrew M., Koren-Morag Nira, Hanson Sandra, Grond Martin, Levine Steven R. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation. 2002 Apr 9;105(14):1679–1685. doi: 10.1161/01.cir.0000012747.53592.6a. [DOI] [PubMed] [Google Scholar]
  27. Tomsick T., Brott T., Barsan W., Broderick J., Haley E. C., Spilker J., Khoury J. Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. AJNR Am J Neuroradiol. 1996 Jan;17(1):79–85. [PMC free article] [PubMed] [Google Scholar]
  28. Tong D. C., Adami A., Moseley M. E., Marks M. P. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging. Arch Neurol. 2001 Apr;58(4):587–593. doi: 10.1001/archneur.58.4.587. [DOI] [PubMed] [Google Scholar]
  29. Tong D. C., Adami A., Moseley M. E., Marks M. P. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke. 2000 Oct;31(10):2378–2384. doi: 10.1161/01.str.31.10.2378. [DOI] [PubMed] [Google Scholar]
  30. Toni D., Fiorelli M., Bastianello S., Sacchetti M. L., Sette G., Argentino C., Montinaro E., Bozzao L. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology. 1996 Feb;46(2):341–345. doi: 10.1212/wnl.46.2.341. [DOI] [PubMed] [Google Scholar]
  31. Trouillas P., Nighoghossian N., Derex L., Adeleine P., Honnorat J., Neuschwander P., Riche G., Getenet J. C., Li W., Froment J. C. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. Stroke. 1998 Dec;29(12):2529–2540. doi: 10.1161/01.str.29.12.2529. [DOI] [PubMed] [Google Scholar]
  32. Ueda T., Hatakeyama T., Kumon Y., Sakaki S., Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke. 1994 Feb;25(2):298–303. doi: 10.1161/01.str.25.2.298. [DOI] [PubMed] [Google Scholar]
  33. del Zoppo G. J., von Kummer R., Hamann G. F. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):1–9. doi: 10.1136/jnnp.65.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. van Swieten J. C., Koudstaal P. J., Visser M. C., Schouten H. J., van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988 May;19(5):604–607. doi: 10.1161/01.str.19.5.604. [DOI] [PubMed] [Google Scholar]
  35. von Kummer R., Meyding-Lamadé U., Forsting M., Rosin L., Rieke K., Hacke W., Sartor K. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol. 1994 Jan;15(1):9–18. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES